In part two of our two-part series, Patrick J. Kennedy, former U.S. Representative and founder of The Kennedy Forum, and Nawal Roy, CEO and founder of global behavioral health data platform Holmusk, discuss with MobiHealthNews how coverage for mental health has changed since the signing of the parity act and what steps the partners are taking to help lawmakers draft even more effective bills to...
Patrick J. Kennedy, former U.S. Representative and founder of the Kennedy Forum, is a leading voice on mental health and addiction. During his 16 years in the U.S. House of Representatives serving Rhode Island's First Congressional District he coauthored and sponsored the Mental Health Parity and Addiction Equity Act, which requires insurers to cover mental health and substance use disorders the...
Behavioural health data analytics company Holmusk has raised $45 million in a Series B funding round led by Veradigm, formerly Allscripts Healthcare Solutions. The round was also joined by its existing investors, Heritas Capital, Health Catalyst Capital, Novartis, and Northwell Holdings.
WHAT IT'S FOR
The Singapore and New York-based company will use its new funds to continue expanding its...
Holmusk signs tech use with US-based mental healthcare provider
US-based Metrocare Services has signed an agreement with Holmusk, a behavioural health tech provider from Singapore, to use its real-world data platform in enhancing mental health care.
Metrocare is a leading provider of mental health and developmental disability services in Texas.
The deal is for the use of NeuroBlu, a data...
Charité-University Medicine Berlin has established a new research partnership with the global data science company Holmusk. The strategic collaboration is focused on the collection and analysis of real-world data from psychiatry.
As Holmusk declared on 22 November, the initiative aims to improve the understanding of psychiatric diseases through evidence-based analytics.
WHY IT MATTERS
The COVID-...
Holmusk, a health tech firm based in Singapore and New York, has signed deals to use patient data from the University of Texas Health Science Center and the Harris Center for Mental Health and IDD to develop AI-powered analytic tools.
WHY IT MATTERS
The company will help create longitudinal patient records in both centres, which are still storing data in various legacy electronic health record...
New Jersey-based Otsuka Pharmaceutical Development & Commercialization has signed a three-year collaboration with Holmusk, a data science and digital health firm based in Singapore and New York. The deal is worth up to $4 million annually.
WHAT THEY DO
OPDC is an indirect unit of Otsuka Pharmaceutical Company, which is a subsidiary of Japan-based Otsuka Holdings. It develops and manufactures...
Singapore-based data science and healthcare technology company Holmusk has signed a Memorandum of Understanding (MoU) with Singapore’s National Healthcare Group (NHG) and the Institute of Mental Health (IMH), to jointly develop innovative solutions for mental healthcare.
WHAT’S IT ABOUT
The MoU outlines a shared vision to use digital technology, data and predictive analytics to help improve the...
Singapore-based data science and healthcare technology company Holmusk announced a collaboration with the Healthcare business sector of German pharma and life sciences giant Merck to support patients and physicians in Asia-Pacific with a holistic treatment approach for prediabetes and diabetes.
The partnership involves Holmusk's GlycoLeap, a mobile digital therapeutics platform that utilizes a...
AIA, the largest public listed pan-Asian life insurance group announced earlier this month that they are forming an exclusive Asia-Pacific (APAC) partnership with data science and healthcare technology company Holmusk.
The partnership will enable AIA to digitally deliver a wider range of health coaching tools and solutions to AIA customers, including AIA Vitality members, leveraging Holmusk’s...
 (2).jpeg?itok=gdBeK6KU)
_4_0.jpeg?itok=t4ZJ33Zu "Real-world data platform could enable large German mental health studies on a ‘Scandinavian scale’.")
 (2).jpg?itok=KmFtfiVu)
